Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Vogt, Annamarie
13  Ergebnisse:
Personensuche X
?
1

A Phase II Study to Evaluate the Safety and Efficacy of Pra..:

Pagano, Gennaro ; Boess, Frank G. ; Taylor, Kirsten I....
Frontiers in Neurology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
2

Early engagement with the wider patient community in early‐..:

Croney, Ruth ; Agnew, David ; Vogt, Annamarie...
Alzheimer's & Dementia.  17 (2021)  S7 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
3

[P3–015]: THE IMPACT OF ELECTRONIC CLINICAL OUTCOME ASSESSM..:

Feaster, H. Todd ; Solomon, Todd M. ; Abi‐Saab, Danielle...
Alzheimer's & Dementia.  13 (2017)  7S_Part_19 - p. , 2017
Link: https://doi.org/10.1016/..
 
?
4

Computerised working memory training in healthy adults: A c..:

Penner, Iris-Katharina ; Vogt, Annamarie ; Stöcklin, Markus...
Neuropsychological Rehabilitation.  22 (2012)  5 - p. 716-733 , 2012
Link: https://doi.org/10.1080/..
 
?
5

Trial of Prasinezumab in Early-Stage Parkinson's Disease:

Pagano, Gennaro ; Taylor, Kirsten I ; Mollenhauer, Brit...
info:eu-repo/semantics/altIdentifier/doi/10.34734/FZJ-2022-03262.  , 2022
Link: https://juser.fz-juelich..
 
?
6

A Phase II Study to Evaluate the Safety and Efficacy of Pra..:

Pagano, Gennaro ; Boess, Frank ; Taylor, Kirsten I...
Frontiers in neurology.  , 2021
Link: https://ddd.uab.cat/reco..
 
?
7

A Phase II Study to Evaluate the Safety and Efficacy of Pra..:

Pagano, Gennaro ; Boess, Frank G ; Taylor, Kirsten I...
qt2tv8r5dg.  , 2021
Link: https://escholarship.org..
 
?
8

A Phase II Study to Evaluate the Safety and Efficacy of Pra..:

Pagano, Gennaro ; Boess, Frank G ; Taylor, Kirsten I...
https://resolver.sub.uni-goettingen.de/purl?gro-2/94461.  , 2021
Link: https://resolver.sub.uni..
 
?
9

Data_Sheet_1_A Phase II Study to Evaluate the Safety and Ef..:

Gennaro Pagano ; Frank G. Boess ; Kirsten I. Taylor...
doi:10.3389/fneur.2021.705407.s001.  , 2021
Link: https://doi.org/10.3389/..
 
?
10

A Phase II Study to Evaluate the Safety and Efficacy of Pra..:

Gennaro Pagano ; Frank G. Boess ; Kirsten I. Taylor...
https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/full.  , 2021
Link: https://doi.org/10.3389/..
 
?
11

Data_Sheet_1_A Phase II Study to Evaluate the Safety and Ef..:

Gennaro Pagano ; Frank G. Boess ; Kirsten I. Taylor...
doi:10.3389/fneur.2021.705407.s001.  , 2021
Link: https://doi.org/10.3389/..
 
?
12

Data_Sheet_1_A Phase II Study to Evaluate the Safety and Ef..:

Gennaro Pagano (291011) ; Frank G. Boess (11512171) ; Kirsten I. Taylor (11512174)...
https://figshare.com/articles/dataset/Data_Sheet_1_A_Phase_II_Study_to_Evaluate_the_Safety_and_Efficacy_of_Prasinezumab_in_Early_Parkinson_s_Disease_PASADENA_Rationale_Design_and_Baseline_Data_docx/17294399.  , 2021
Link: https://doi.org/10.3389/..
 
?
13

Data_Sheet_1_A Phase II Study to Evaluate the Safety and Ef..:

Gennaro Pagano (291011) ; Frank G. Boess (11512171) ; Kirsten I. Taylor (11512174)...
https://figshare.com/articles/dataset/Data_Sheet_1_A_Phase_II_Study_to_Evaluate_the_Safety_and_Efficacy_of_Prasinezumab_in_Early_Parkinson_s_Disease_PASADENA_Rationale_Design_and_Baseline_Data_docx/16722577.  , 2021
Link: https://doi.org/10.3389/..
 
1-13